Revery International Group Berhad (REVERY International) is proud to announce the launch of ReLabo, which is the first exosome-based home treatment created with EXO BioComplex now available in Malaysia.
Revery International Group Berhad (REVERY International) is proud to announce the launch of ReLabo, which is the first exosome-based home treatment created with EXO BioComplex now available in Malaysia. This groundbreaking anti-aging solution harnesses stem cell-derived exosomes combined with potent skincare components to offer a revolutionary at-home treatment. With ReLabo as their source of reassurance, Malaysians can now access non-invasive, science-backed skincare solutions designed to deliver visible results without the need for surgery or downtime.
Today’s consumers demand personalised skincare solutions to address effect of aging from photoaging, lifestyle and environment. Globally, the anti-aging market is rapidly growing, which leads to the need for non-invasive treatments that provide professional results at home to be higher. Recognising that this demand is growing and that the consumer demographic seeking anti-aging solutions is becoming younger particularly among consumers aged 26 to 35, REVERY International has invested more than RM5 million in research and development to create the safest and most effective solutions for anti-aging.
As a global leader in biomedical research and innovation, REVERY International is on the rise, bringing new developments to the beauty and wellness industry. Ms Tiffany Loh, Founder and CEO of REVERY International, expressed that ReLabo represents a significant leap in biotechnology and skincare innovation, improving the quality of life for those seeking effective, science-backed skincare solutions.
“ReLabo embodies our commitment to providing professional and effective anti-aging solutions that empower women to regain their confidence. Our breakthrough ingredient in all ReLabo products,
